Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action. | Toxins (Basel) | 2023 | 37999488 | PubTator, text mining | PubMed |
| The Impact of Palliative Care on Mitigating Pain and Its Associated Effects in Determining Quality of Life among Colon Cancer Outpatients. | Healthcare (Basel) | 2023 | 37998446 | PubTator, text mining | PubMed |
| LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability. | J Transl Med | 2023 | 37990271 | PubTator, text mining | PubMed |
| Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology. | Biomark Res | 2023 | 37978566 | PubTator, text mining | PubMed |
| Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level. | Cell Cycle | 2023 | 37974462 | PubTator, text mining | PubMed |
| Comparison of in-gel and in-solution proteolysis in the proteome profiling of organ perfusion solutions. | Clin Proteomics | 2023 | 37968584 | PubTator, text mining | PubMed |
| Metabolic predictors of response to immune checkpoint blockade therapy. | iScience | 2023 | 37965137 | PubTator, text mining | PubMed |
| Delivery and Transcriptome Assessment of an In Vitro Three-Dimensional Proximal Tubule Model Established by Human Kidney 2 Cells in Clinical Gelatin Sponges. | Int J Mol Sci | 2023 | 37958530 | PubTator, text mining | PubMed |
| HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification. | Cell Death Discov | 2023 | 37957183 | PubTator, text mining | PubMed |
| Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells. | Front Cell Dev Biol | 2023 | 37954205 | PubTator, text mining | PubMed |
| Characteristics of lactate metabolism phenotype in hepatocellular carcinoma. | Sci Rep | 2023 | 37952028 | PubTator, text mining | PubMed |
| Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer. | BMC Med Genomics | 2023 | 37950222 | PubTator, text mining | PubMed |
| The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. | Basic Res Cardiol | 2023 | 37938421 | PubTator, text mining | PubMed |
| A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis. | Acta Orthop Belg | 2023 | 37935218 | PubTator, text mining | PubMed |
| Endometrial Glucose Metabolism During Early Pregnancy. | Reprod Fertil | 2023 | 37934727 | PubTator, text mining | PubMed |
| Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation. | Front Endocrinol (Lausanne) | 2023 | 37929027 | PubTator, text mining | PubMed |
| The role of lactate in cardiovascular diseases. | Cell Commun Signal | 2023 | 37924124 | PubTator, text mining | PubMed |
| FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review. | Front Oncol | 2023 | 37916161 | PubTator, text mining | PubMed |
| MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells. | iScience | 2023 | 37915591 | PubTator, text mining | PubMed |
| Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases. | Front Pharmacol | 2023 | 37915411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=14